Lion Point Capital’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-693,778
| Closed | -$1.22M | – | 25 |
|
|
2024
Q3 | $1.22M | Sell |
693,778
-1,421,049
| -67% | -$2.5M | 2.72% | 8 |
|
|
2024
Q2 | $2.47M | Sell |
2,114,827
-4,309
| -0.2% | -$5.04K | 4.51% | 5 |
|
|
2024
Q1 | $19.2M | Sell |
2,119,136
-15,201
| -0.7% | -$137K | 10.71% | 1 |
|
|
2023
Q4 | $23.2M | Sell |
2,134,337
-11,000
| -0.5% | -$120K | 11.61% | 2 |
|
|
2023
Q3 | $17.3M | Sell |
2,145,337
-112,184
| -5% | -$903K | 7.7% | 2 |
|
|
2023
Q2 | $24.5M | Sell |
2,257,521
-362,575
| -14% | -$3.94M | 11.08% | 2 |
|
|
2023
Q1 | $18.1M | Sell |
2,620,096
-1,602,552
| -38% | -$11.1M | 7.44% | 4 |
|
|
2022
Q4 | $21.5M | Buy |
4,222,648
+538,026
| +15% | +$2.74M | 3.06% | 3 |
|
|
2022
Q3 | $19M | Hold |
3,684,622
| – | – | 4.18% | 4 |
|
|
2022
Q2 | $19M | Buy |
3,684,622
+55,000
| +2% | +$283K | 2.16% | 5 |
|
|
2022
Q1 | $33.9M | Hold |
3,629,622
| – | – | 7.87% | 2 |
|
|
2021
Q4 | $43.1M | Hold |
3,629,622
| – | – | 11.56% | 1 |
|
|
2021
Q3 | $41.3M | Sell |
3,629,622
-2,072
| -0.1% | -$23.6K | 7.74% | 1 |
|
|
2021
Q2 | $65.2M | Buy |
3,631,694
+13,360
| +0.4% | +$240K | 11.26% | 1 |
|
|
2021
Q1 | $56M | Hold |
3,618,334
| – | – | 10.19% | 1 |
|
|
2020
Q4 | $44.1M | Buy |
3,618,334
+900,000
| +33% | +$11M | 8.5% | 4 |
|
|
2020
Q3 | $34.9M | Sell |
2,718,334
-1
| -0% | -$13 | 7.66% | 4 |
|
|
2020
Q2 | $27.6M | Buy |
2,718,335
+1,124,650
| +71% | +$11.4M | 6.7% | 4 |
|
|
2020
Q1 | $12.9M | Hold |
1,593,685
| – | – | 3.41% | 7 |
|
|
2019
Q4 | $13.8M | Buy |
1,593,685
+730,926
| +85% | +$6.32M | 1.28% | 14 |
|
|
2019
Q3 | $5.31M | Buy |
+862,759
| New | +$5.31M | 0.59% | 19 |
|